Robitussin and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is found among people who take Robitussin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Robitussin and have Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 3,053 people who have side effects when taking Robitussin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 12, 2023

3,053 people reported to have side effects when taking Robitussin.
Among them, 43 people (1.41%) have Chronic obstructive pulmonary disease.

What is Robitussin?

Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,061 Robitussin users for its effectiveness, alternative drugs and more.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,797 drugs and 2,051 conditions by eHealthMe.

Number of Robitussin and Chronic obstructive pulmonary disease reports submitted per year:

Could Robitussin cause Chronic obstructive pulmonary disease?

Time on Robitussin when people have Chronic obstructive pulmonary disease *:

Gender of people who have Chronic obstructive pulmonary disease when taking Robitussin *:

female: 62.79 %
male: 37.21 %

Age of people who have Chronic obstructive pulmonary disease when taking Robitussin *:

Common drugs people take besides Robitussin *:

Common side effects people have besides Chronic obstructive pulmonary disease *:

Pneumonia: 19 people, 44.19%
Breathing Difficulty: 15 people, 34.88%
Fatigue (feeling of tiredness): 15 people, 34.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 15 people, 34.88%
Dehydration (dryness resulting from the removal of water): 13 people, 30.23%
Productive Cough: 11 people, 25.58%
Cough: 10 people, 23.26%
Cardiac Failure Congestive: 10 people, 23.26%
Wheezing (a high-pitched whistling sound made while you breath): 10 people, 23.26%
Hypotension (abnormally low blood pressure): 9 people, 20.93%

Common conditions people have *:

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 25.58%
Cough: 4 people, 9.30%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 9.30%
High Blood Pressure: 3 people, 6.98%
Hiv Infection: 3 people, 6.98%
Pain: 3 people, 6.98%
Immunodeficiency Common Variable: 2 people, 4.65%
Hypersensitivity: 2 people, 4.65%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 4.65%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take Robitussin and have Chronic obstructive pulmonary disease?

Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Chronic obstructive pulmonary disease and when was it recovered:

Chronic obstructive pulmonary disease in Robitussin

Expand to all the drugs that have ingredients of guaifenesin:

Chronic obstructive pulmonary disease and drugs with ingredients of guaifenesin (884 reports)

Alternative drugs to, pros and cons of Robitussin:

Robitussin (3,061 reports)

Common Robitussin side effects:

Cough: 247 reports
Fatigue (feeling of tiredness): 243 reports
Breathing difficulty: 242 reports
Pneumonia: 230 reports
Diarrhea: 190 reports
Nausea and vomiting: 179 reports
Pain: 176 reports
Weakness: 175 reports

Browse all side effects of Robitussin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic obstructive pulmonary disease treatments and more:

Chronic obstructive pulmonary disease (180,025 reports)

COVID vaccines that are related to Chronic obstructive pulmonary disease:

Common drugs associated with Chronic obstructive pulmonary disease:

All the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,797 drugs)

Common conditions associated with Chronic obstructive pulmonary disease:

Rheumatoid arthritis: 3,895 reports
Osteoporosis: 3,472 reports
Asthma: 3,370 reports
High blood pressure: 3,274 reports

All the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,051 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin (the active ingredients of Robitussin) and Robitussin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.